'Serious adverse' presentation slideshows

DAIDS Regional Training Event, Johannesburg, South Africa, August 2012

926 views • 80 slides

Causality Assessment Training ACTG Network Meeting June 20, 2011

Causality Assessment Training ACTG Network Meeting June 20, 2011. Ling Chin, MD, MPH Safety Pharmacovigilance Team Leader, DAIDS. Olu Og unyankin , MD DAIDS RSC Safety & Pharmacovigilance Specialist. Deborah McMahon , MD University of Pittsburgh ACTG - PEC. Training Agenda.

1.76k views • 65 slides

Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): Training Update

NHSBT CTU. Platelets for Neonatal Transfusion Study 2 (PlaNeT-2): Training Update A randomised controlled trial of platelet transfusion thresholds. NHSBT Clinical Trials Unit. NHSBT CTU. Neonatal Thrombocytopenia. Prevalence: 1 - 5% of all newborns 25% NICU admissions

789 views • 53 slides

Meningococcal A,C,Y,W135 Conjugate Vaccine (Menactra TM )

Aventis Pasteur, Inc. Meningococcal A,C,Y,W135 Conjugate Vaccine (Menactra TM ). Lucia H. Lee CBER, FDA. Vaccines and Related Biological Products Advisory Committee Meeting September 22, 2004. Outline. Proposed Basis for Licensure: 11-55 years old Clinical Studies

810 views • 48 slides

1.27k views • 38 slides

Staying true to the protocol Vidheya Venkatesh

NHSBT CTU. Staying true to the protocol Vidheya Venkatesh. The Delegation Log. GCP training CVs Delineation of roles: consenting training. The Screening log. Removal of Patient identifiable data Remember to send monthly. NHSBT Clinical Trials Unit. NHSBT CTU. Pre randomisation.

358 views • 26 slides